These changes in PGRMC1 expression levels and subcellular localization are consistent with the finding that patients with high tumor levels of PGRMC1 have a poorer prognosis and shorter disease-free state [41] (Figure 1F). The gene discussed is PGRMC1; the disease is neoplasm.